Table 5.
Antimicrobials reported, method used, type of data reported and interpretive criteria applied by MSs for human Campylobacter AST data in 2015
| Country | Ciprofloxacin | Co‐amoxiclav | Erythromycin | Gentamicin | Tetracyclines | Method used | Quantitative (Q) or categorical (SIR) | Interpretive criteria |
|---|---|---|---|---|---|---|---|---|
| Austria | ● | ● | ● | ● | DL | Q | Interpreted by ECDC. EUCAST ECOFF (CIP, ERY, GEN, TET), CA‐SFM CBP 2015 (AMC) | |
| Cyprus | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria | ||
| Denmark | ● | ● | ● | ● | DL | Q | Interpreted by ECDC, as for Austria | |
| Estonia | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria | ||
| Finland | ● | ● | ● | DD/DLG | Q | Interpreted by ECDC, as for Austria | ||
| France | ● | ● | ● | ● | ● | DD | SIR | EUCAST CBP 2013 (CIP, ERY, TET), CA‐SFM CBP 2015 (AMC, GEN) |
| Iceland | ● | ● | DD/DLG | SIR | EUCAST CBP 2015 | |||
| Italy | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria | ||
| Lithuania | ● | ● | ● | DD | SIR | EUCAST CBP 2015 | ||
| Luxembourg | ● | ● | ● | ● | DD/DLG | Q | Interpreted by ECDC, as for Austria | |
| Malta | ● | ● | DLG/DD/DL | SIR | EUCAST CB 2014 | |||
| Netherlands | ● | ● | ● | DD/DL | SIR | Survey in 12 clinical labs in NL in 2009 (Ned Tijdschr Med Microbiol 2009;17:nr1) | ||
| Norway | ● | ● | ● | ● | DL | Q | Interpreted by ECDC, as for Austria | |
| Portugal | ● | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria | |
| Romania | ● | ● | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria |
| Slovakia | ● | ● | ● | ● | ● | DL | SIR | In 2013, CLSI CB |
| Slovenia | ● | ● | ● | DD | Q | Interpreted by ECDC, as for Austria | ||
| Spain | ● | ● | ● | ● | ● | DLG | Q | Interpreted by ECDC, as for Austria |
| United Kingdom | ● | ● | ● | DD/DL/DLG | SIR | Varies depending on clinical microbiology laboratory |
MSs: Member States; AST: antimicrobial susceptibility testing; DD: disk diffusion; DL: dilution; DLG: dilution with gradient strip; Q: quantitative data; SIR: susceptible, intermediate, resistant (categorical data); ECDC: European Centre for Disease Prevention and Control; EUCAST: European Committee on Antimicrobial Susceptibility Testing; CA‐SFM: French Society for Microbiology; ECOFF: epidemiological cut‐off; CBP: clinical breakpoint; CIP: ciprofloxacin; ERY: erythromycin; GEN: gentamicin; TET: tetracycline; AMC: amoxicillin/clavulanate.
Antimicrobials tested.